In a report released today, Tony Ren from Macquarie maintained a Hold rating on Olympus, with a price target of Yen2,000.00. The company’s shares closed last Tuesday at $12.42.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Ren is a 4-star analyst with an average return of 16.2% and a 64.10% success rate. Ren covers the Healthcare sector, focusing on stocks such as Chugai Pharmaceutical Co, Olympus, and Sysmex.
In addition to Macquarie, Olympus also received a Hold from TR | OpenAI – 4o’s Jack Scalprey in a report issued on October 11. However, on October 7, TR | OpenAI – 4o upgraded Olympus (Other OTC: OCPNF) to a Buy.
The company has a one-year high of $20.00 and a one-year low of $10.66. Currently, Olympus has an average volume of 554.
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
/Cybersecurity%20by%20AIBooth%20via%20Shutterstock.jpg)
